Recordati Industria Chimica e Farmaceutica S.p.A. Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Recordati Industria Chimica e Farmaceutica S.p.A. Stock Forecast and Price Target
Recordati Industria Chimica e Farmaceutica S.p.A.'s stock price reaches the average target of 50.70€ by 2025 as expected recently by notable experts, there would be a potential upside of approximately 1.93% from the last closing price in April, 2024. This possible increase is based on a high estimate of 57.00€ and a low estimate of 43.00€. If interested in REC stock, you may also want to consider its competitors.
1.93% Upside
Recordati Industria Chimica e Farmaceutica S.p.A. Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Recordati Industria Chimica e Farmaceutica S.p.A.'s Price has decreased by 100.00%, from 46.49€ to 0.00€. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach 52.56€ – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Recordati Industria Chimica e Farmaceutica S.p.A. will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£109.14 | Buy/Sell | £165.99 | 48.27% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.27 | Buy/Sell | $118.92 | 20.64% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.39 | Buy/Sell | $32.87 | 20.13% |
| 4502 Stock Forecast | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | Buy/Sell | ¥4.74k | 13.72% |
| ARGX Stock Forecast | argenx | Outperform |
4
|
342.00€ | Buy/Sell | 531.81€ | 28.36% |
Recordati Industria Chimica e Farmaceutica S.p.A. Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Revenue for Recordati Industria Chimica e Farmaceutica S.p.A. has grown by 27.91%, going from 1.45€B to 1.85€B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach 2.27€B – an increase of 22.70%. Over the next seven years, experts anticipate that Revenue growth for Recordati Industria Chimica e Farmaceutica S.p.A. will be 61.12%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GMAB Stock Forecast | Genmab A/S | Outperform |
16
|
kr1.99k | Buy/Sell | kr2.71k | 28.60% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.12 | Buy/Sell | $11.73 | 7.91% |
| IPN Stock Forecast | Ipsen | Outperform |
17
|
106.30€ | Buy/Sell | 127.95€ | 10.07% |
.jpg)
Recordati Industria Chimica e Farmaceutica S.p.A. Dividend per Share Forecast for 2023 - 2025 - 2030
Recordati Industria Chimica e Farmaceutica S.p.A.'s Dividend per Share has grown in the last two years, jumping from 1.05€ to 1.15€ – an increase of 9.52%. In the next year, analysts predict that Dividend per Share will reach 1.39€ – an increase of 20.87%. For the next seven years, the forecast is for Dividend per Share to grow by 50.79%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHDN Stock Forecast | Churchill Downs | Outperform |
16
|
$119.30 | Buy/Sell | $143.67 | 20.28% |
| ZEAL Stock Forecast | Zealand Pharma A/S | Outperform |
8
|
kr598.00 | Buy/Sell | kr357.00 | 36.29% |
| ORNBV Stock Forecast | Orion Oyj | Hold |
14
|
32.27€ | Buy/Sell | 42.52€ | 30.15% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£17.89 | Buy/Sell | £28.11 | 65.34% |
| ALK B Stock Forecast | ALK-Abelló A/S | Outperform |
13
|
kr125.60 | Buy/Sell | kr109.25 | 5.89% |
| ALRM Stock Forecast | Alarm.com Holdings | Outperform |
16
|
$64.30 | Buy/Sell | $67.13 | 28.46% |
Recordati Industria Chimica e Farmaceutica S.p.A. EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Recordati Industria Chimica e Farmaceutica S.p.A.'s EBITDA has grown, increasing from 558.98€M to 659.21€M – an increase of 17.93%. For next year, the 8 analysts predict EBITDA of 841.31€M, which would mean an increase of 27.62%. Over the next seven years, the pros' prediction is EBITDAof 1.11€B, which would mean a seven-year growth forecast of 68.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VIRP Stock Forecast | Virbac | Outperform |
18
|
373.00€ | Buy/Sell | 348.34€ | -1.07% |
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.60 | Buy/Sell | $9.50 | 16.28% |
| PENN Stock Forecast | PENN Entertainment | Outperform |
13
|
$16.14 | Buy/Sell | $29.89 | 54.89% |
Recordati Industria Chimica e Farmaceutica S.p.A. EBIT Forecast for 2023 - 2025 - 2030
Recordati Industria Chimica e Farmaceutica S.p.A.'s EBIT has increased by 14.51% In the last two years, going from 475.49€M to 544.47€M. In the next year, analysts expect EBIT to reach 661.97€M – an increase of 21.58%. For the next seven years, the forecast is for EBIT to grow by 68.60%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MOR Stock Forecast | MorphoSys | Outperform |
6
|
67.70€ | Buy/Sell | 28.78€ | 0.44% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
13.45€ | Buy/Sell | 37.33€ | 89.59% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$22.66 | Buy/Sell | $35.67 | 67.70% |
Recordati Industria Chimica e Farmaceutica S.p.A. EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Recordati Industria Chimica e Farmaceutica S.p.A.'s EPS has decreased by 100.00%, from 1.99€ to 0.00€. In the coming year, analysts are expecting an increase in EPS, predicting it will reach 2.25€ – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Recordati Industria Chimica e Farmaceutica S.p.A. will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£15.24 | Buy/Sell | £28.89 | 106.69% |
| ALM Stock Forecast | Almirall | Outperform |
16
|
8.18€ | Buy/Sell | 11.39€ | 40.59% |
| COPN Stock Forecast | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF71.20 | Buy/Sell | CHF76.55 | 32.12% |
Site Navigation
.jpg)